Last reviewed · How we verify
NCT06929390
Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety
NA trial testing BTVA in Copd in 26 participants. Not yet recruiting.
31 December 2028
Quick facts
| Lead sponsor | Henan Provincial People's Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 1 May 2025 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2028 |
Drugs / interventions tested
- BTVA
- MWA
Conditions studied
- Copd — all drugs for Copd →
- Lung Cancer — all drugs for Lung Cancer →
Sponsor
Henan Provincial People's Hospital
Who can join
Adults 35 to 80, any sex, with Copd or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Based on the advantages of BTVA in the treatment of early-stage lung cancer and COPD, researchers propose the concept of using BTVA to treat COPD combined with early-stage lung cancer. Researchers plan to conduct a multicenter clinical study focusing on patients with COPD combined with malignant GGNs. Bronchoscopic BTVA surgery or percutaneous MWA surgery will be performed, evaluating the effectiveness and safety of bronchoscopic BTVA and percutaneous MWA surgery in the treatment of COPD combined with early-stage lung cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06929390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Copd
Currently open trials in the same condition.
- NCT06461403 — Inhaler Trainer Efficacy Study · NA · recruiting
- NCT07285642 — Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT07027852 — My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record · NA · recruiting
- NCT06286072 — The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD · NA · recruiting
- NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting
Other Henan Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07268872 — Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers · NA · enrolling by invitation
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT07033871 — Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - O · not yet recruiting
- NCT06853808 — Prediction Model for Delayed Extubation of Tracheal Intubation in Patients With Maxillofacial Space Infection After Absc · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06929390 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henan Provincial People's Hospital
- Last refreshed: 18 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06929390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing